Dept. of Surgery, Division of HPB & Transplant Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Dept. of Surgery, Division of HPB & Transplant Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Int J Surg. 2016 Aug;32:83-8. doi: 10.1016/j.ijsu.2016.05.063. Epub 2016 Jun 1.
Living kidney donors comprise a unique group of "patients", undergoing an operation for the benefit of others. The informed consent process is therefore valued differently. Although this is a team effort, the surgeon is responsible for performing the donor nephrectomy, and often the one held accountable, should adverse events occur. Although there is some consensus on how the informed consent procedure should be arranged, practices vary. The aim of this study was to evaluate the surgical informed consent procedure for live donor nephrectomy, with special regards to disclosure of complications.
A web-based survey was sent to all kidney transplant surgeons (n = 50) in eight transplant centers with questions regarding the local procedure and disclosure of specific details.
Response rate was 98% (n = 49), of which 32 (65%) were involved in living donor education; overall, transplant- (50%), vascular- (31%), and abdominal surgeons (13%), and urologists (6%) performed donor nephrectomies in the eight centers. Informed consent procedures varied, ranging from assumed to signed consent. Bleeding was the only complication every surgeon mentioned. Risk of death was always mentioned by 16 surgeons (50%), sometimes by 13 (41%), three surgeons (9%) never disclosed this disastrous complication. Reported mortality rates ranged from 0.003% to 0.1%. Mentioning frequencies for all other complications varied.
Important complications are not always disclosed during the surgical informed consent process for live donor nephrectomy. Informed consent procedures vary. To optimally prepare living kidney donors for the procedure, a standardized informed consent procedure for live donor nephrectomy is highly recommended.
活体肾脏捐献者是一群独特的“患者”,他们为了他人的利益接受手术。因此,知情同意过程的价值就有所不同。尽管这是一个团队的努力,但外科医生负责进行供体肾切除术,并且如果发生不良事件,往往是外科医生承担责任。尽管对于如何安排知情同意程序有一些共识,但实践做法却有所不同。本研究旨在评估活体供肾切除术的手术知情同意程序,特别是在披露并发症方面。
我们向 8 个移植中心的所有肾脏移植外科医生(n=50)发送了一份基于网络的调查,其中包含有关当地程序和具体细节披露的问题。
回复率为 98%(n=49),其中 32 名(65%)参与了活体供者教育;总体而言,移植外科医生(50%)、血管外科医生(31%)和腹部外科医生(13%)以及泌尿科医生(6%)在这 8 个中心进行了供体肾切除术。知情同意程序各不相同,从假定同意到签署同意。每位外科医生都提到了出血是唯一的并发症。16 名外科医生(50%)始终提到死亡风险,13 名外科医生(41%)有时提到,3 名外科医生(9%)从未披露过这种灾难性的并发症。报告的死亡率范围从 0.003%到 0.1%。所有其他并发症的提及频率也各不相同。
在活体供肾切除术的手术知情同意过程中,并非所有重要的并发症都得到了披露。知情同意程序各不相同。为了使活体肾脏捐献者最佳地为手术做好准备,强烈建议制定标准化的活体供肾切除术知情同意程序。